Tag: chief scientific officer

May 8, 2018

New Preclinical Data for Novel Immunotherapy Bispecific Candidate ALG.APV-527 Presented by Aptevo Therapeutics and Alligator Bioscience at Prominent Industry Conferences

Aptevo Therapeutics (Nasdaq:APVO), a biotechnology company focused on developing novel immuno-oncology and hematology therapeutics, and Alligator Bioscience (Nasdaq Stockholm:ATORX), a...
May 7, 2018

International Stem Cell Corporation Granted Key Patent in US

International Stem Cell Corporation (OTCQB:ISCO) a California-based biotechnology company developing novel stem cell based therapies and biomedical products, announced today that...
May 4, 2018

Tetra Bio-Pharma Will Distribute PPP001 in Portugal

Tetra Bio-Pharma announced a binding term sheet for the marketing and distribution of its lead candidate PPP001, a smokable cannabis...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 26, 2018

Achaogen Wins CARB-X Funding Award to Advance Development of Novel Aminoglycoside to Fight Highly

Achaogen (NASDAQ:AKAO), a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative infections, today announced that it has...
April 19, 2018

Hemostemix Announces US FDA Clinical Trial Approval

Hemostemix (TSXV:HEM), a clinical-stage, autologous cell-therapy company, is pleased to announce that the United States Food and Drug Administration has raised...
April 19, 2018

XORTX Announces PKD Foundation Collaboration

XORTX Therapeutics (CSE:XRX) is pleased to announce that the PKD Foundation has recognized XORTX as a leader in advancing the...